<bill session="115" type="h" number="6608" updated="2019-04-18T16:26:47Z">
  <state datetime="2018-07-26">REFERRED</state>
  <status>
    <introduced datetime="2018-07-26"/>
  </status>
  <introduced datetime="2018-07-26"/>
  <titles>
    <title type="official" as="introduced">To provide for the development and dissemination of best practice guidelines for using data collected by prescription drug monitoring programs to identify drug diversion and abuse, and for other purposes.</title>
    <title type="short" as="introduced">Prescription Drug Monitoring Program Best Practices Act of 2018</title>
    <title type="short" as="introduced">Prescription Drug Monitoring Program Best Practices Act of 2018</title>
    <title type="display">Prescription Drug Monitoring Program Best Practices Act of 2018</title>
  </titles>
  <sponsor bioguide_id="M001197"/>
  <cosponsors>
    <cosponsor bioguide_id="C001096" joined="2018-07-26"/>
  </cosponsors>
  <actions>
    <action datetime="2018-07-26">
      <text>Introduced in House</text>
    </action>
    <action datetime="2018-07-26" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2018-07-27">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <committee-reports/>
</bill>
